article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

Additionally, the industry’s highly regulated nature means that executives must have a keen eye for compliance and a strong ability to navigate the ever-changing market dynamics. In addition to industry expertise, biotech executive search firms must demonstrate their ability to adapt to the evolving demands of the market.

Execution 437
article thumbnail

How to Get Yourself Invited to Important Meetings

Harvard Business Review

She was on the legal compliance team at a fast-growing biotechnology company. Her role was to work with marketing to ensure that promotional campaigns and materials were in line with government guidelines. When I spoke with Karen’s marketing colleagues, they told me that they found her presence in meetings frustrating.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Political Issues Board Directors Care Most About

Harvard Business Review

If their projections turn out to be right, we should get ready for a bumpy road ahead, with market volatility and negative surprises. They’re frustrated by the complexity of the regulatory environment and the time and expense associated with compliance and other regulatory obligations.

article thumbnail

Joining Boards: It's Not Just Who You Know That Matters

Harvard Business Review

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., banking & financial services, insurance, real estate); Health Care (e.g.,

article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business Review

It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. It also allows companies to assess real-world challenges that cannot be observed in a clinical trial, such as drug compliance and the utilization of health care resources.